# Study to Evaluate GSK2190915 in Subjects With Mild Asthma

> **NCT00812773** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 17 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GSK2190915

## Key facts

- **NCT ID:** NCT00812773
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812773, "Study to Evaluate GSK2190915 in Subjects With Mild Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00812773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*